MESNA

N/A

Manufactured by Bamboo US Bidco LCC

16,399 FDA adverse event reports analyzed

Last updated: 2026-04-14

About MESNA

MESNA is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Bamboo US Bidco LCC. The most commonly reported adverse reactions for MESNA include FEBRILE NEUTROPENIA, PYREXIA, OFF LABEL USE, NEUTROPENIA, THROMBOCYTOPENIA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for MESNA.

Top Adverse Reactions

FEBRILE NEUTROPENIA1,247 reports
PYREXIA676 reports
OFF LABEL USE642 reports
NEUTROPENIA565 reports
THROMBOCYTOPENIA381 reports
ANAEMIA376 reports
VOMITING368 reports
NAUSEA355 reports
SEPSIS354 reports
PANCYTOPENIA343 reports
MUCOSAL INFLAMMATION337 reports
DIARRHOEA336 reports
PNEUMONIA281 reports
DISEASE PROGRESSION274 reports
DEATH255 reports
ENCEPHALOPATHY231 reports
HYPOTENSION224 reports
PLATELET COUNT DECREASED222 reports
DRUG INEFFECTIVE213 reports
PRODUCT USE IN UNAPPROVED INDICATION212 reports
WHITE BLOOD CELL COUNT DECREASED201 reports
ACUTE KIDNEY INJURY198 reports
INFECTION197 reports
LEUKOPENIA194 reports
FATIGUE183 reports
NEUTROPHIL COUNT DECREASED174 reports
DYSPNOEA168 reports
SEPTIC SHOCK165 reports
CYTOKINE RELEASE SYNDROME163 reports
PAIN155 reports
HEADACHE154 reports
HYPOKALAEMIA151 reports
CONFUSIONAL STATE148 reports
TOXICITY TO VARIOUS AGENTS145 reports
BACTERIAL INFECTION143 reports
CYSTITIS HAEMORRHAGIC141 reports
MYELOSUPPRESSION141 reports
STOMATITIS135 reports
NEUROTOXICITY134 reports
ABDOMINAL PAIN129 reports
HYPERTENSION127 reports
HAEMOGLOBIN DECREASED126 reports
DECREASED APPETITE125 reports
TACHYCARDIA124 reports
PLEURAL EFFUSION122 reports
DRUG INTERACTION119 reports
CHILLS116 reports
GENERAL PHYSICAL HEALTH DETERIORATION114 reports
RENAL FAILURE113 reports
BRONCHOPULMONARY ASPERGILLOSIS112 reports
APLASTIC ANAEMIA110 reports
ASTHENIA109 reports
VIRAL INFECTION106 reports
MALIGNANT NEOPLASM PROGRESSION105 reports
NEUROPATHY PERIPHERAL105 reports
RESPIRATORY FAILURE105 reports
BACK PAIN104 reports
HAEMATOTOXICITY102 reports
PSEUDOMONAL SEPSIS102 reports
RASH98 reports
CONSTIPATION96 reports
MYELODYSPLASTIC SYNDROME96 reports
FUNGAL INFECTION95 reports
CELLULITIS92 reports
CLOSTRIDIUM DIFFICILE COLITIS91 reports
DEHYDRATION91 reports
ALANINE AMINOTRANSFERASE INCREASED89 reports
MALAISE87 reports
HAEMATURIA86 reports
MULTIPLE ORGAN DYSFUNCTION SYNDROME86 reports
SECONDARY IMMUNODEFICIENCY83 reports
ATRIAL FIBRILLATION81 reports
COUGH78 reports
CYTOMEGALOVIRUS VIRAEMIA78 reports
HYPONATRAEMIA78 reports
PRODUCT USE ISSUE78 reports
CARDIAC ARREST77 reports
CYTOPENIA77 reports
HYPOXIA77 reports
URINARY TRACT INFECTION77 reports
BONE MARROW FAILURE76 reports
DIZZINESS76 reports
WEIGHT DECREASED76 reports
ALOPECIA72 reports
ASPARTATE AMINOTRANSFERASE INCREASED72 reports
BACTERAEMIA72 reports
RENAL FAILURE ACUTE72 reports
VENOOCCLUSIVE LIVER DISEASE72 reports
RESPIRATORY DISTRESS68 reports
NEUTROPENIC SEPSIS67 reports
EPISTAXIS66 reports
THERAPY NON RESPONDER66 reports
CYTOMEGALOVIRUS INFECTION64 reports
COLITIS63 reports
MENTAL STATUS CHANGES63 reports
C REACTIVE PROTEIN INCREASED62 reports
VENOOCCLUSIVE DISEASE62 reports
LYMPHOCYTE COUNT DECREASED61 reports
PULMONARY EMBOLISM61 reports
AGRANULOCYTOSIS60 reports

Report Outcomes

Out of 8,107 classified reports for MESNA:

Serious 96.9%Non-Serious 3.1%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male3,397 (52.1%)
Female2,966 (45.5%)
Unknown156 (2.4%)

Reports by Age

Age 16160 reports
Age 61146 reports
Age 3132 reports
Age 15130 reports
Age 67126 reports
Age 55114 reports
Age 59114 reports
Age 64113 reports
Age 14112 reports
Age 69109 reports
Age 20106 reports
Age 13104 reports
Age 60102 reports
Age 6699 reports
Age 1095 reports
Age 294 reports
Age 893 reports
Age 5793 reports
Age 792 reports
Age 5692 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with MESNA?

This profile reflects 16,399 FDA FAERS reports that mention MESNA. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for MESNA?

Frequently reported terms in FAERS include FEBRILE NEUTROPENIA, PYREXIA, OFF LABEL USE, NEUTROPENIA, THROMBOCYTOPENIA, ANAEMIA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures MESNA?

Labeling and FAERS entries often list Bamboo US Bidco LCC in connection with MESNA. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.